These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16389293)

  • 1. Ropinirole, a non-ergoline dopamine agonist.
    Jost WH; Angersbach D
    CNS Drug Rev; 2005; 11(3):253-72. PubMed ID: 16389293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ropinirole: current status of the studies.
    Jost WH
    J Neurol; 2004 Sep; 251 Suppl 6():VI/13-8. PubMed ID: 15675719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole: a dopamine agonist for the treatment of Parkinson's disease.
    Kuzel MD
    Am J Health Syst Pharm; 1999 Feb; 56(3):217-24. PubMed ID: 10030505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole in the symptomatic treatment of Parkinson's disease.
    Brooks DJ; Torjanski N; Burn DJ
    J Neural Transm Suppl; 1995; 45():231-8. PubMed ID: 8748630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole: a review of its use in the management of Parkinson's disease.
    Matheson AJ; Spencer CM
    Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole for levodopa-induced complications in Parkinson's disease.
    Clarke CE; Deane KH
    Cochrane Database Syst Rev; 2000; (3):CD001516. PubMed ID: 10908503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies with ropinirole in Parkinson's disease and RLS.
    Jost WH; Angersbach D; Rascol O
    J Neurol; 2006 Aug; 253 Suppl 4():IV16-21. PubMed ID: 16944351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease.
    Iskedjian M; Einarson TR
    Pharmacoeconomics; 2003; 21(2):115-27. PubMed ID: 12515573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole therapy for Parkinson's disease.
    Pahwa R; Lyons KE; Hauser RA
    Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing dopamine agonists in Parkinson's disease.
    Bonuccelli U
    Curr Opin Neurol; 2003 Dec; 16 Suppl 1():S13-9. PubMed ID: 15180133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of a pharmacokinetic interaction at steady state between ropinirole and L-dopa in patients with Parkinson's disease.
    Taylor AC; Beerahee A; Citerone DR; Cyronak MJ; Leigh TJ; Fitzpatrick KL; Lopez-Gil A; Vakil SD; Burns E; Lennox G
    Pharmacotherapy; 1999 Feb; 19(2):150-6. PubMed ID: 10030765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of ropinirole in patients with idiopathic Parkinson's disease.
    Titlic M; Tonkic A; Jukic I; Lusic I; Dikanovic M
    Bratisl Lek Listy; 2008; 109(6):273-5. PubMed ID: 18700440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
    Thalamas C; Taylor A; Brefel-Courbon C; Eagle S; Fitzpatrick K; Rascol O
    Eur J Clin Pharmacol; 1999 Jun; 55(4):299-303. PubMed ID: 10424323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K; Lyons KE
    Pharmacotherapy; 2009 Dec; 29(12):1452-67. PubMed ID: 19947805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-512, a novel dopamine D
    Lindenbach D; Das B; Conti MM; Meadows SM; Dutta AK; Bishop C
    Br J Pharmacol; 2017 Sep; 174(18):3058-3071. PubMed ID: 28667675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic agonists in the treatment of Parkinson's disease].
    Supiot F; Sternon J; Zegers de Beyl D
    Rev Med Brux; 2000 Dec; 21(6):493-9. PubMed ID: 11194495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ropinirole treatment for restless legs syndrome.
    Chitnis S
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):655-64. PubMed ID: 18484922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ropinirole in the treatment of restless legs].
    Hellebek A; Kampmann JP
    Ugeskr Laeger; 2005 Jun; 167(23):2541; author reply 2541-2. PubMed ID: 16008015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.